To Study the effect of Udumber Twak Ghanvati in Asrugdara.
Phase 2
- Registration Number
- CTRI/2020/10/028229
- Lead Sponsor
- Dr Sayali Gourishankar Belage
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Written informed consent & voluntarily willing patients will be taken for this study.
2)Patients complaining of excessive or prolonged menstrual bleeding or inter menstrual bleeding for 2 consecutive cycles.
3)Hb % - Above 8 gm%.
Exclusion Criteria
1)Patients with IUCD and on OC pills or on hormonal treatment.
2)PCOD,STD,Blood coagulopathy.
3) Immunoâ?? compromised patients.
4)Associated with other systemic diseases like HTN, TB, DM.
5)Bleeding from polyps,fibroid, Ca, erosions, trauma etc.
6)On medication like Aspirin, clopitab.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Asrugdara is the common problem noticed in majority of patients in our clinical practice. <br/ ><br>2) To evatuate and establish safer,cost-effective Ayurvedic remedy for Asrugdara. <br/ ><br> <br/ ><br>Timepoint: Patient should be assessed for 3 consecutive cycles for 1st 5 days of menstrual flow <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1)To improve physiological condition <br/ ><br>2)To give her a safe cheap side effect free ayurvedic managementTimepoint: 90 days